Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Laurie Keefer, PhD While diagnosing irritable bowel syndrome and inflammatory bowel disease is critical to care, treating these illnesses and improving quality of life is just as important. Joining Dr. Peter Buch to share strategies to help counsel and care for our patients beyond diagnosis is Dr. Laurie Keefer, Professor of Medicine, Gastroenterology, and Psychiatry at Mount Sinai School of Medicine.
May 21, 20210
Host: Neilanjan Nandi, MD Guest: Kate Scarlata, MPH, RDN Many patients tailor their diets to their gastrointestinal disorders, such as IBS, and adopt a low FODMAP regimen. What skills do we need to help screen patients for FODMAP sensitivities and identify foods they should avoid? Dr. Neil Nandi will be discussing these skills with Kate Scarlata, a registered dietitian, and a New York Times best-selling author.
May 21, 20210
Host: Neilanjan Nandi, MD Guest: Aline Charabaty, MD Many of us use social media to stay connected with family and friends. But have you ever considered using social media to communicate with other clinicians and even earn CME credit? Clinical Director of Gastroenterology and Director of the Inflammatory Bowel Disease Center at Sibley Memorial Hospital Dr. Aline Charabaty saw that opportunity and used it to create Monday Night IBD, and now Dr. Charabaty is here to talk about that program and the...
May 20, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Cynthia L Sears, M.D. Decreased resistance to antibiotics has adversely impacted our ability to fight H. pylori. How can we help our patients overcome this threat? Dr. Peter Buch is here today to discuss this issue with Dr. Cynthia Sears, professor of medicine at the Johns Hopkins University School of Medicine to help improve health outcomes for our patients.
May 20, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Douglas Drossman, MD Guest: Johannah Ruddy, MEd Gender bias and trauma are prevalent issues that have far-reaching impacts on our GI patients’ health and even our diagnostic and treatment approaches. To learn more about how gender bias and trauma impact patients and clinicians alike, Dr. Peter Buch is joined by Dr. Douglas Drossman and patient advocate Ms. Johanna Ruddy from the Rome Foundation.
May 07, 20210
Host: Neilanjan Nandi, MD Guest: Austin Chiang, MD, MPH The field of endoscopic bariatric weight loss has developed over the years, but there’s a lot we still don’t know. Dr. Neil Nandi is here today with Dr. Austin Chiang, Director of the Endoscopic Bariatric Program at Thomas Jefferson University Hospital, to provide some insight on advanced endoscopy for bariatric weight loss.
Apr 28, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Arlene Wright, DNP, APRN, FNP-BC, FNAP Thanks to recent research and advancements, our understanding and treatment of gastroesophageal reflux disease (GERD) has greatly evolved over the years. So what do we now know about diagnosing and treating this common GI disorder? Find out with Dr. Peter Buch and Dr. Arlene Wright, President of the Florida Nurse Practitioner Network and Executive Vice President of the Nurse Practitioners of Lee County, Florida....
Apr 27, 20210
Host: Neilanjan Nandi, MD Guest: Freddy Caldera, DO Many IBD patients have received their COVID-19 vaccine, but many others still have reservations due to the abundance of myths and misconceptions surrounding the COVID-19 vaccines. That’s why Dr. Neil Nandi welcomes Dr. Freddy Caldera to discuss these common fears and challenges as well as some of the very best answers to address the concerns of our immunosuppressed IBD patients.
Apr 26, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Rajeev Attam, MD Pancreatic cysts may be detected in up to 50 percent of patients undergoing intraabdominal MR imaging. But not all of them are malignant, so how can we determine which patients need further testing, monitoring, and perhaps even surgery? Joining Dr. Peter Buch to answer that and other questions is gastroenterologist Dr. Rajeev Attam.
Apr 21, 20210
Host: Neilanjan Nandi, MD Guest: David T. Rubin, MD How has the COVID-19 pandemic impacted patients with IBD? Dr. Neil Nandi is here to answer our COVID-19 questions for our IBD patients with Dr. David Rubin, Professor of Medicine at the University of Chicago Pritzker School of Medicine.
Apr 21, 20210
Host: Neilanjan Nandi, MD Guest: David T. Rubin, MD With more data emerging on COVID-19 vaccines every day, what do our patients with inflammatory bowel disease need to know about the vaccine currently available? Dr. Neil Nandi will be discussing these updates and how we can keep our patients safe with Dr. David Rubin, Professor of Medicine at the University of Chicago Pritzker School of Medicine.
Apr 21, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Colin T. Swales, MD From cirrhosis to liver cancer, there are many dangers associated with non-alcoholic fatty liver disease. So what are some best practices for managing this condition? Dr. Peter Buch sits down with Dr. Colin Swales, Assistant Medical Director of Transplant Services at Harvard Hospital, to discuss the management of non-alcoholic fatty liver disease.
Apr 20, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Colin T. Swales, MD How can we help the two to four million Americans who are living with hepatitis C? Joining Dr. Peter Buch to answer this question and share treatment strategies for various case scenarios is hepatologist Dr. Colin Swales, Assistant Medical Director of Transplant Services at Harvard Hospital.
Apr 20, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Colin T. Swales, MD Should sobriety and drug abstinence be required for hepatitis C therapy? Dr. Peter Buch dives into this dilemma with Dr. Colin Swales, Assistant Medical Director of Transplant Services at Harvard Hospital, as he walks us through both sides of this controversial issue.
Apr 20, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Adam Olsen, MS, PA-C Millions of patients are treated with anticoagulants, and many more are treated with antiplatelet therapy. But when those therapies overlap with GI bleeding, what do you need to know so that your patients don’t experience any problematic health outcomes? Dr. Peter Buch is discussing this topic with physician assistant Mr. Adam Olsen, who’s the Department Chair and Program Director for the Master of Physician Assistant Studies Pro...
Apr 15, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Douglas Drossman, MD Guest: Johannah Ruddy, MEd Patients suffering from disorders of the gut-brain interaction are often subjected to stigma. But what can we do to help challenge these stigmas? Here today is Dr. Peter Buch who will be joined by Dr. Douglas Drossman, President of the Rome Foundation, and Ms. Johanna Ruddy, Executive Director of the Rome Foundation, to talk about the impact of stigma in DGBI.
Apr 13, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Douglas Drossman, MD Guest: Johannah Ruddy, MEd Strong communication is a critical component in improving health outcomes for patients with IBS. What do we need to know to help our patients feel heard and valued? Dr. Peter Buch is joined by Dr. Douglas Drossman, President of the Rome Foundation, and Ms. Johanna Ruddy, Executive Director of the Rome Foundation, to discuss how to effectively communicate with our patients....
Apr 13, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Andres Nieto, MD The COVID-19 pandemic has demonstrated the effectiveness of telemedicine, but will this approach still be utilized after the pandemic ends? Dr. Peter Buch is joined by Dr. Andres Nieto, Assistant Professor at Frank H. Netter MD School of Medicine, to discuss the role of telemedicine and its future
Apr 05, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Scott Gabbard, MD Dyspepsia affects a large number of Americans. But what exactly is dyspepsia? And how can we distinguish dyspepsia from other diseases? Joining Dr. Peter Buch to answer those and other questions is Dr. Scott Gabbard, who’s the section head of the Neurogastroenterology and Motility Center at the Cleveland Clinic.
Apr 02, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: John Allen, MD The world of healthcare continues to drastically change over the years. But what do you need to know about the variety of employment models available for gastroenterologists today? Dr. Peter Buch is joined by Dr. John Allen, Clinical Professor of Medicine at the University of Michigan School of Medicine, to discuss recent changes in practice models.
Apr 01, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Douglas K. Rex, MD Millions of colonoscopies are performed each year in the United States, but which indicators should we be using to measure the quality of these procedures? Dr. Peter Buch is joined by Dr. Douglas Rex, Distinguished Professor Emeritus of Medicine at Indiana University School of Medicine, to discuss the importance of these indicators.
Apr 01, 20210
Host: Neilanjan Nandi, MD Guest: Folasade P. May, MD, PhD, MPhil Racial and ethnic bias prevent patients with colorectal cancer from receiving the highest quality of care. Dr. Neil Nandi is joined by Dr. Fola May, Assistant Professor of Medicine at UCLA, to discuss racial inequalities in access to care and screening for patients with colorectal cancer.
Mar 25, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Nicole Hanley-Williams, MD The management of motility disorders like achalasia and gastroparesis can be very complex for both patients and clinicians alike. Fortunately, there have been several advancements in the evaluation and treatment of these disorders. Joining Dr. Peter Buch to walk us through what those developments are and how they can help improve our patients’ quality of life is Dr. Nicole Hanley-Williams, who specializes in motility and fu...
Mar 18, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Philip Ginsburg, MD Tofacitinib is a common treatment option for patients with ulcerative colitis. But it’s not without its risks. Here to share what we need to consider before we start our patients on tofacitinib is Dr. Philip Ginsburg, Medical Director of Research and the Director of the Inflammatory Bowel Disease Center of Connecticut.
Mar 17, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Philip Ginsburg, MD With so many treatment options currently available for moderate to severe Crohn’s disease and ulcerative colitis, how do you know which one will work best for your patients? Joining Dr. Peter Buch to help answer that and other questions is Dr. Philip Ginsburg, Medical Director of Research and the Director of the Inflammatory Bowel Disease Center of Connecticut.
Mar 17, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Jeffrey Basile, MD Now that we have therapies like vedolizumab and ustekinumab, many are wondering if there’s still a role for anti-TNFs in the treatment of IBD. Here to share his perspective and how he uses the multitude of available treatment options to his advantage is Dr. Jeffrey Basile, a gastroenterologist from Charleston GI.
Mar 16, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Jeffrey Basile, MD The treatment and evaluation of inflammatory bowel disease, or IBD, is continuously changing to provide the best quality of care for patients. Dr. Peter Buch is joined by Dr. Jeffrey Basile, a gastroenterologist from Charleston GI, to shed some light on the latest treatment options for IBD patients.
Mar 16, 20210
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Feuerstadt, MD, FACG, AGAF Clostridium difficile impacts many patients around the United States. How can we better diagnose and treat this infection? Dr. Peter Buch is joined by Dr. Paul Feuerstadt, Assistant Clinical Professor of Medicine at Yale New Haven Hospital the discuss the importance of managing Clostridium difficile.
Mar 02, 20210
Host: Neilanjan Nandi, MD Guest: Brian E. Lacy, MD, PhD What do we need to know about choosing the right medication for our patients with IBS? Stay tuned as Dr. Neil Nandi talks with Dr. Brain Lacy, a gastroenterologist at the Mayo Clinic, Jacksonville, and the co-editor-in-chief of the American Journal of Gastroenterology, on these pharmacologic therapies.
Feb 26, 20210
Host: Neilanjan Nandi, MD Guest: Brian E. Lacy, MD, PhD Irritable bowel syndrome can be difficult to manage for both physicians and patients. What can we do to help better diagnose and manage IBS? Here today is Dr. Neil Nandi who is discussing the IBS Guidelines highlights with Dr. Brain Lacy, a gastroenterologist at the Mayo Clinic, Jacksonville, Florida, and the co-editor-in-chief of the American Journal of Gastroenterology .
Feb 26, 20210
